The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients

• Verfasst von: Buchheidt, Dieter [VerfasserIn]
• Verfasst von: Hofmann, Wolf-Karsten [VerfasserIn]
• Verfasst von: Spiess, Birgit [VerfasserIn]
• Verfasst von: Boch, Tobias [VerfasserIn]
• Titel: The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients
• Titelzusatz: strengths and weaknesses
• Verf.angabe: Dieter Buchheidt, Mark Reinwald, Martin Hoenigl, Wolf-karsten Hofmann, Birgit Spiess, and Tobias Boch
• E-Jahr: 2017
• Jahr: 2017/12/01
• Umfang: 6 S.
• Fussnoten: Gesehen am 16.05.2018
• Titel Quelle: Enthalten in: Current opinion in infectious diseases
• Ort Quelle: London : Lippincott Williams & Wilkins, 1988
• Jahr Quelle: 2017
• Band/Heft Quelle: 30(2017), 6, Seite 539-544
• ISSN Quelle: 1473-6527
• ISSN Quelle: 1535-3877
• DOI: doi:10.1097/QCO.0000000000000408
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1575173069

Abstract

The diagnosis of invasive aspergillosis in hematologic patients is a complex composite of clinical preconditions and features, imaging findings, biomarker combinations from appropriate clinical samples and microbiological and/or histological findings. Recent developments in the evolving landscape of diagnostic tests for invasive aspergillosis in adult hematology patients are highlighted. Novel approaches and tools are currently under development. Focusing optimized diagnostic performance, in particular the combination of biomarkers from appropriate clinical samples, improved diagnostic performance distinctly.